4HAHR A J, MOLITCH M E. Diabetes, cardiovascular risk and nephropathy[J]. Cardiol Clin, 2010,28 : 467 -475.
5Ameriean Diabetes Association. Standards of medical care in diabetes-2010[J]. Diabetes Care, 2010,33 :S11 -S61.
6MOJAHEDI M J, BONAKDARAN S, HAMI M, et al. Elevated serum C-reactive protein level and mi croalbuminuria in patients with type 2 diabetes mellitus[J]. Iran J Kidney Dis, 2009,3 : 12- 16.
7DATTA P,DASGUPTA A. An improved microalbumin method (microALB 2) with extended analytical measurement range evaluated on the ADVIA chemistry systems[J]. J ('lin Lab Anal,2009,23:314-318.
8Haseeb KA, Samia SH, Abdullah SA, et al. Paired values of serum frumcosamtine and blood glucose for the screening of gestational daibetes mellitus:a retrospective study of 165 saudi pregnant women [J]. Ind J ofClin Bioch, 2007, 22(1): 65-70.
9Mormier L, Lapinski H, Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c)[J]. Diabetes Care, 2003, 26(3): 881-5.
